Background: Small clinical trials are necessary when there are difficulties in recruiting enough patients for conventional frequentist statistical analyses to provide an appropriate answer. These trials are often necessary for the study of rare diseases as well as specific study populations e.g. children. It has been estimated that there are between 6,000 and 8,000 rare diseases that cover a broad range of diseases and patients. In the European Union these diseases affect up to 30 million people, with about 50% of those affected being children. Therapies for treating these rare diseases need their efficacy and safety evaluated but due to the small number of potential trial participants, a standard randomised controlled trial is ofte
OBJECTIVE: Frequentist trials in Rare disease/small population trials often require unfeasibly large...
"Patients in rare diseases should be entitled to the same quality of treatment as other patients". T...
Rare diseases are diseases with prevalence of lower than one in 2,000 individuals. Jointly, rare dis...
Background: Small clinical trials are necessary when there are difficulties in recruiting enough pat...
International audienceBACKGROUND: Small clinical trials are necessary when there are difficulties in...
Background: Small clinical trials are necessary when there are difficulties in recruiting enough pat...
Small clinical trials are trials in which the number of patients does not enable the objective of th...
Background: Orphan drug development faces numerous challenges, including low disease prevalence, pat...
Since clinical trials for rare disease subjects have a small number of patients, it is difficult to ...
Background: Clinical trials in rare diseases are more challenging than trials in frequent diseases. ...
Background: Clinical trials in rare diseases are more challenging than trials in frequent diseases. ...
International audienceBackgroundMost statistical design and analysis methods for clinical trials hav...
Abstract Background Clinical trials in rare diseases are more challenging than trials in frequent di...
OBJECTIVE: Frequentist trials in Rare disease/small population trials often require unfeasibly large...
"Patients in rare diseases should be entitled to the same quality of treatment as other patients". T...
Rare diseases are diseases with prevalence of lower than one in 2,000 individuals. Jointly, rare dis...
Background: Small clinical trials are necessary when there are difficulties in recruiting enough pat...
International audienceBACKGROUND: Small clinical trials are necessary when there are difficulties in...
Background: Small clinical trials are necessary when there are difficulties in recruiting enough pat...
Small clinical trials are trials in which the number of patients does not enable the objective of th...
Background: Orphan drug development faces numerous challenges, including low disease prevalence, pat...
Since clinical trials for rare disease subjects have a small number of patients, it is difficult to ...
Background: Clinical trials in rare diseases are more challenging than trials in frequent diseases. ...
Background: Clinical trials in rare diseases are more challenging than trials in frequent diseases. ...
International audienceBackgroundMost statistical design and analysis methods for clinical trials hav...
Abstract Background Clinical trials in rare diseases are more challenging than trials in frequent di...
OBJECTIVE: Frequentist trials in Rare disease/small population trials often require unfeasibly large...
"Patients in rare diseases should be entitled to the same quality of treatment as other patients". T...
Rare diseases are diseases with prevalence of lower than one in 2,000 individuals. Jointly, rare dis...